Titlebook: Recent Developments in Graves’ Ophthalmopathy; Mark F. Prummel,Wilmar M. Wiersinga (Professor of Book 2000 Springer Science+Business Medi

含糊

,Immunosuppressive management of Graves’ ophthalmopathy, of both, are the most frequently used immunosuppressive therapies, but other treatments like cyclosporine, azathioprine, intravenous immunoglobulins, and plasma exchange, have also been used (Table 1).

獨(dú)輪車(chē)

,Future Research in Graves’ ophthalmopathy,acter too, and that the TSH-R is an important antigen also in the pathogenesis of the eye signs. This chapter tries to summarize recent developments in endocrine autoimmunity in general and Graves’ ophthalmopathy in particular.

Enteropathic

Book 2000e disease. Each chapter is written by anexpert and truly represents the current state of the art on theparticular topic. This book can therefore almost be considered atextbook on this enigmatic disorder. ..Recent Developments in Graves‘ Ophthalmopathy. is designed forall those interested in this dis

SLING

欲望

,Thyroid management in Graves’ ophthalmopathy,nts with Graves’ hyperthyroidism, subclinical evidence for orbital disease is present in almost all patients.. This close association has always been the most pertinent reason to think that the ophthalmopathy and the thyroid disorder are actually two manifestations of the same condition: Graves’ disease.

misshapen

,Radiotherapy for Graves’ ophthalmopathy,treatments and the treatment schedules used. The prevention of keloid formation was the most widely accepted indication, followed by Graves’ ophthalmopathy. Thus, radiotherapy for this orbital disorder is generally accepted and applied worldwide.

Abnormal

GUILT

奴才

晚間